You are here
Alerts
This page shows all our alerts. These are Safety alerts, Medicine shortage alerts and Product recalls. You can sort the list with the filters on the left, use the search bar or both.
For more information see Product safety.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Alert/Advisory (1116)
- Medicines safety (497)
- Medical devices safety (342)
- Shortages (71)
- Safety (50)
- Prescription medicines (40)
- Regulatory compliance (15)
- Listed medicines (14)
- Import and export (13)
- Over the counter (OTC) medicines (11)
- Complementary medicines (10)
- Therapeutic goods regulation (9)
- Blood safety (8)
- Australian Register of Therapeutic Goods (ARTG) (5)
- Non-prescription medicines (5)
- Advertising (3)
- Sunscreens (3)
- Breast implant hub (2)
- Labelling and packaging (2)
- Legislation (2)
- Assessed listed medicines (1)
- Clinical trials (1)
- Compliance and enforcement hub (1)
- Registered complementary medicines (1)
Type of content
Results for
"[search-keyword]"
Search
1313 result(s) found, displaying 51 to 75
- Recall: Space Saver Shower Stool RG554H2Recall actionsThe Space Saver Shower Stool (RG554H2) is being recalled due to potential for the seat section to crack. You can return the seat for a refund. Find out more about the recall by the FOR-DE Group.
- Recall: Logiwash and Legency Remedies Sodium Chloride 0.9% ampoulesRecall actionsTesting indicates the presence of Ralstonia pickettii in additional saline products manufactured at Legency Remedies Private. All batches of these products are now being recalled from the Australian market.
- Safety alert and product recalls: updated advice following Ralstonia pickettii contamination of some saline productsRecall actionsWe're continuing to investigate and take action on the potential contamination of some saline products with Ralstonia pickettii. Read about the latest round of product recalls.
- Synchromed II Infusion Pump: caution after MRIRecall actionsMedtronic Australasia Pty Ltd is alerting patients who have an implanted SynchroMed II Pump that it may not function properly after they undergo a Magnetic Resonance Imaging (MRI) procedure.
- Compounding safety information: semaglutide-like productsSafety alertsWe are aware of an emerging trend for telehealth providers to offer compounded semaglutide-like products. Compounded semaglutide-like products are ‘unapproved’ therapeutic goods and have not been evaluated by us for safety, quality and efficacy.
- Shortage of Bicillin L-A (benzathine benzylpenicillin tetrahydrate) prefilled syringe for injectionMedicine shortage alertsWe have been notified of a shortage of Bicillin L-A (benzathine benzylpenicillin) and are working with stakeholders to provide advice to patients and healthcare professionals
- BAIWEI Maximum Powerful tablets safety advisorySafety alertsBAIWEI Maximum Powerful tablets pose a serious risk to your health and should not be taken. They contain the undeclared substance sildenafil, which may interact with some prescription drugs. This may lower your blood pressure to dangerous levels.
- Bigger Longer More Time More Sperms capsules safety advisorySafety alertsBigger Longer More Time More Sperms capsules pose a serious risk to your health and should not be taken. They contain the undeclared substance sildenafil, which may interact with some prescription drugs. This may lower your blood pressure to dangerous levels.
- Li Da Daidaihua capsules safety advisorySafety alertsLi Da Daidaihua capsules pose a serious risk to your health and should not be taken. They contain the undeclared substance sibutramine. This increases the risk of cardiac events and stroke.
- Recall: Kin Fertility - The Prenatal capsulesRecall actionsKin Fertility Pty Ltd is recalling several batches of The Prenatal capsules due to reported quality problems with the capsules. There is no indication of any safety concerns.
- Substitution approved for fluoxetine 20 mg dispersible tablets (Zactin Tabs)Medicine shortage alertsA Serious Scarcity Substitution Instrument (SSSI) is now approved to assist with the shortage of fluoxetine 20mg dispersible tablets
- Ying Da Wang tablets safety advisorySafety alertsYing Da Wang tablets pose a serious risk to your health and should not be taken. They contain the undeclared substance sildenafil, which may interact with some prescription drugs. This may lower your blood pressure to dangerous levels.
- Romosozumab (Evenity) safety alertSafety alertsThere are new warnings about the risks of heart attack and stroke with taking romosozumab (Evenity). The Product Information (PI) and Consumer Medicine Information (CMI) have been updated to reflect these risks.
- Sitagliptin diabetes medicines safety advisorySafety alertsOur safety advisory includes information for consumers and health professionals about low levels of nitrosamine impurity in medicines containing sitagliptin.
- Action about CPAP and BiPAP face and nasal masks that contain magnetsSafety alertsWe're continuing to monitor adverse events from masks that have magnets interacting with implantable medical devices. Find out how we're working with companies supplying these devices in Australia and international regulators.
- Recall: Interpharma Sodium Chloride 0.9% 30mL ampoulesRecall actionsInterpharma Pty Ltd is recalling all batches of Sodium Chloride 0.9% 30mL ampoules due to potential contamination with Ralstonia pickettii. You can return them for a refund.
- Safety alert: action following potential contamination of some saline products with Ralstonia pickettiiSafety alertsWe're continuing to investigate and take action about the potential contamination of some saline products with Ralstonia pickettii. Read about a product recall and quarantines.
- Shortage of Mounjaro (tirzepatide) injectionsMedicine shortage alertsThe availability of all strengths of Mounjaro (tirzepatide) will be limited until 31 August 2024, due to unexpected high demand. Patients and healthcare professionals should check the Medicine Shortage Reports Database for the latest supply information.
- Safety alert: potential contamination of some saline products with Ralstonia pickettiiSafety alertsWe're aware of Ralstonia pickettii cases in patients across Australia and are working closely with health departments to investigate the possible role of therapeutic goods.
- Safety advisory: DuloxetineSafety alertsRead information for consumers and health professionals about low levels of nitrosamine impurity in medicines containing duloxetine.
- Safety advisory: FluoxetineSafety alertsFind out how we are investigating low levels of the nitrosamine impurity in medicines containing fluoxetine. Read information for consumers and health professionals.
- Shortage of fluoxetine 20 mg dispersible tablets (Zactin Tabs)Medicine shortage alertsThere's a shortage of fluoxetine 20 mg dispersible tablets (Zactin Tabs) due to manufacturing issues. The shortage is expected to continue until 29 February 2024.
- Safety alert: APOHEALTH Paracetamol Pain ReliefSafety alertsIf you've purchased APOHEALTH Paracetamol Pain Relief paracetamol 500 mg film-coated tablets in a bottle, ensure it is kept out of reach of children. This product does not have child-resistant packaging.
- Resmed Masks with MagnetsRecall actionsResMed Pty Ltd is updating the safety information and warnings for their masks that have magnets.
- Recall: BioCeuticals Zinc DropsRecall actionsFIT-BioCeuticals Pty Ltd is recalling two batches of BioCeuticals Zinc Drops. In these batches, the zinc and the liquid are separating, which means that you may not get the correct dose of zinc.